Literature DB >> 22682142

Risk and management of thrombosis in multiple myeloma.

Frank W G Leebeek1, Marieke J H A Kruip, Pieter Sonneveld.   

Abstract

Patients diagnosed with multiple myeloma have an increased risk of venous thrombosis. This may be due to various risk factors, including disease specific factors, changes in coagulation and fibrinolysis factors and circulating prothrombotic microparticles. More recent studies have indicated that also arterial thrombosis, including acute myocardial infarction and stroke do occur more frequently in these patients. Studies on etiological factors contributing to the development of thrombosis will be reviewed in this article. In addition we will focus on the prevention and management of arterial and venous thrombosis in patients with multiple myeloma.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682142     DOI: 10.1016/S0049-3848(12)70024-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Assessment of oxidative/nitrative modifications of plasma proteins, selected ROTEM parameters and kinetics of fibrinogen polymerization in patients with multiple myeloma at diagnosis.

Authors:  W Nowak; J Treliński; K Chojnowski; J Matczak; M Robak; M Misiewicz; P Nowak
Journal:  Med Oncol       Date:  2016-11-30       Impact factor: 3.064

2.  Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma.

Authors:  Shosaku Nomura; Tomoki Ito; Hideaki Yoshimura; Masaaki Hotta; Takahisa Nakanishi; Shinya Fujita; Aya Nakaya; Atsushi Satake; Kazuyoshi Ishii
Journal:  J Blood Med       Date:  2018-01-19

3.  The independent association of mean platelet volume with overall survival in multiple myeloma.

Authors:  Qiang Zhuang; Lina Xiang; Hanyan Xu; Fang Fang; Chongyun Xing; Bin Liang; Kang Yu; Jianhua Feng
Journal:  Oncotarget       Date:  2016-09-20

4.  Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma.

Authors:  Thøger Nielsen; Søren Risom Kristensen; Henrik Gregersen; Elena Manuela Teodorescu; Gunna Christiansen; Shona Pedersen
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.